FBXO28 and hepatocellular carcinoma: As seen in the Supplementary Fig. S2A–E, FBXO28 deficiency consistently enhanced cell migration ability, while re-expression of the protein markedly reduced the potentiated migration ability in either cell line, fully supporting a negative regulation of FBXO28 toward HCC migration.